Emad El-Omar

Q: What Schools Are Affiliated With Emad El-Omar

Emad El-Omar is affiliated with the following schools: University of New South Wales, Vanderbilt University, University of Aberdeen

Emad El-Omar's AcademicInfluence.com Rankings

Emad El-Omar

Philosophy

#7137

World Rank

#10304

Historical Rank

Logic

#4211

World Rank

#5473

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Emad El-Omar's Degrees

Masters Medicine University of Aberdeen
PhD Gastroenterology University of Aberdeen

Why Is Emad El-Omar Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Emad Munir El-Omar is a British physician and gastroenterologist who chairs the department of medicine at the University of New South Wales and is the editor in chief of The BMJ's Gut academic journal.

(See a Problem?)

Emad El-Omar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Interleukin-1 polymorphisms associated with increased risk of gastric cancer (2000) (2424)
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report (2006) (2333)
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report (2012) (2271)
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report (2016) (2261)
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. (2013) (1628)
Kyoto global consensus report on Helicobacter pylori gastritis (2015) (1167)
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. (2003) (934)
Helicobacter pylori infection and chronic gastric acid hyposecretion. (1997) (659)
Host-bacterial interactions in Helicobacter pylori infection. (2008) (630)
Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. (1998) (558)
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. (1995) (553)
IBD—what role do Proteobacteria play? (2012) (517)
Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. (2004) (369)
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. (2002) (369)
Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. (2000) (350)
The importance of interleukin 1β inHelicobacter pylori associated disease (2001) (331)
Cancer and Inflammation: Promise for Biologic Therapy (2010) (319)
OLGA staging for gastritis: a tutorial. (2008) (300)
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? (2014) (294)
Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. (1993) (281)
Timing of the Last Glacial Maximum from observed sea-level minima (2001) (276)
Microbiota of De-Novo Pediatric IBD: Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis (2012) (270)
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. (2007) (266)
Cellular and molecular aspects of gastric cancer. (2006) (261)
The stomach in health and disease (2015) (239)
Polymorphisms in Toll-like receptor genes and risk of cancer (2008) (239)
Genetics of gastric cancer (2014) (209)
Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. (2011) (188)
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. (2017) (181)
The Inflammatory Microenvironment in Colorectal Neoplasia (2011) (162)
A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. (1993) (159)
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus (2020) (154)
Gastric Cancer as Preventable Disease (2017) (153)
Detection of Campylobacter concisus and Other Campylobacter Species in Colonic Biopsies from Adults with Ulcerative Colitis (2011) (148)
Role of the polymorphic IL‐1B, IL‐1RN and TNF‐A genes in distal gastric cancer in Mexico (2005) (144)
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma (2021) (133)
Genetic aspects of inflammation and cancer. (2008) (126)
Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles (2020) (123)
Helicobacter Pylori associated global gastric cancer burden. (2009) (122)
Helicobacter pylori gastritis and gastric physiology. (2000) (122)
correction: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer (2001) (120)
The role of infection in the aetiology of inflammatory bowel disease (2010) (119)
The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. (1998) (116)
Sporadic colorectal cancer--role of the commensal microbiota. (2005) (115)
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022) (115)
A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. (1995) (114)
Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. (1994) (110)
Enterohepatic Helicobacter in Ulcerative Colitis: Potential Pathogenic Entities? (2011) (110)
Symptomatic benefit 1–3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease (2000) (108)
Increase in NF-κB Binding Affinity of the Variant C Allele of the Toll-Like Receptor 9 −1237T/C Polymorphism Is Associated with Helicobacter pylori-Induced Gastric Disease (2009) (104)
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial (2016) (104)
Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. (2008) (102)
Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. (2007) (101)
Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. (1998) (101)
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial. (2019) (99)
Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions. (2008) (96)
Revision of the Atlanta classification of acute pancreatitis: the editorial perspective (2012) (95)
Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice (2018) (94)
The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. (1997) (88)
Anticancer effects of bioactive berry compounds (2014) (88)
The Role of Cytokine Gene Polymorphisms in Colorectal Cancer and Their Interaction with Aspirin Use in the Northeast of Scotland (2004) (83)
Could Helicobacter organisms cause inflammatory bowel disease? (2011) (83)
The Glasgow Dyspepsia Severity Score – a tool for the global measurement of dyspepsia (1996) (82)
Two-stage Genome-wide Methylation Profiling in Childhood-onset Crohn's Disease Implicates Epigenetic Alterations at the VMP1/MIR21 and HLA Loci (2014) (81)
Gastric cancer and H. pylori: Host genetics open the way. (2001) (79)
Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease (2018) (78)
Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations (2012) (76)
Helicobacter pylori infection and gastric cancer. (2007) (75)
Helicobacter pylori infection, host genetics and gastric cancer (2009) (75)
Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. (2011) (74)
A Comprehensive Evaluation of Colonic Mucosal Isolates of Sutterella wadsworthensis from Inflammatory Bowel Disease (2011) (73)
Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori (2006) (68)
Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study. (2010) (67)
The fungal microbiota of de-novo paediatric inflammatory bowel disease (2015) (67)
Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. (1994) (67)
The Microaerophilic Microbiota of De-Novo Paediatric Inflammatory Bowel Disease: The BISCUIT Study (2013) (63)
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy. (2004) (62)
Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. (1996) (61)
Interplay of the Gastric Pathogen Helicobacter pylori with Toll-Like Receptors (2015) (60)
Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects. (2020) (57)
Characteristics of Helicobacter pylori‐Induced Gastritis and the Effect of H. pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura (2004) (56)
Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers(Fig. 1) (1999) (55)
Interleukin 1Β proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy (2005) (55)
CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations (2009) (54)
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection. (2018) (53)
Mannose‐binding lectin‐2 genetic variation and stomach cancer risk (2006) (52)
Endometriosis and the microbiome: a systematic review (2020) (51)
Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP‐2 among Helicobacter pylori seropositive Japanese (2006) (49)
Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More (2019) (48)
Gastric cancer. (2008) (47)
Helicobacter pylori Does Not Require Lewis X or Lewis Y Expression To Colonize C3H/HeJ mice (2002) (46)
Toxigenic Helicobacter pylori Infection Precedes Gastric Hypochlorhydria in Cancer Relatives, and H. pylori Virulence Evolves in These Families (2008) (46)
The interplay between Helicobacter pylori and gastrointestinal microbiota (2021) (45)
Marked rebound acid hypersecretion after treatment with ranitidine. (1996) (45)
Role of host genes in sporadic gastric cancer. (2006) (45)
Current status of Barrett's esophagus research in Asia (2011) (45)
Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection (2006) (44)
Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in rats. (1993) (43)
Extending colonic mucosal microbiome analysis—assessment of colonic lavage as a proxy for endoscopic colonic biopsies (2016) (42)
Helicobacter pylori: host genetics and disease outcomes (2008) (42)
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers (2009) (42)
Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer. (1996) (41)
Polymorphisms in Cytokine Genes and Risk of Helicobacter pylori Infection among Jamaican Children (2006) (39)
The role of gastrin in ulcer pathogenesis. (2000) (39)
The role of the microbiome and the NLRP3 inflammasome in the gut and lung (2020) (39)
Role of host genetics in fibrosis (2009) (35)
Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. (2008) (33)
The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk. (2003) (33)
Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention (2019) (32)
Images of colonic real-time tissue sonoelastography correlate with those of colonoscopy and may predict response to therapy in patients with ulcerative colitis (2011) (30)
Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland (2014) (28)
Alterations in gastric physiology in Helicobacter pylori infection: causes of different diseases or all epiphenomena? (1997) (28)
The role of H. pylori infection in the pathophysiology of duodenal ulcer disease. (1997) (27)
Helicobacter pylori and malignant lymphoma in Spain. (2004) (27)
The interaction of host genetic factors and Helicobacter pylori infection (2007) (26)
Assessment of symptomatic response as predictor ofHelicobacter pylori status following eradication therapy in patients with ulcer (1998) (26)
COX‐2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics (2008) (26)
How does H. pylori infection cause gastric cancer? (2002) (25)
[Role of polymorphism of certain cytokines in gastric cancer in Mexico. Preliminary results]. (2003) (22)
The role of Helicobacter pylori in the pathophysiology of duodenal ulcer disease and gastric cancer. (1997) (22)
Genetics of inflammation in the gastrointestinal tract and how it can cause cancer. (2011) (22)
Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential? (2013) (21)
Not all mice are the same: Standardization of animal research data presentation (2016) (20)
Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s Disease (2013) (19)
Helicobacter pylori infection (2010) (19)
Gastrin releasing peptide and its value in assessing gastric secretory function (1995) (18)
The mesenchyme in malignancy: a partner in the initiation, progression and dissemination of cancer. (2012) (18)
The TLR4 D299G and T399I SNPs Are Constitutively Active to Up-Regulate Expression of Trif-Dependent Genes (2014) (17)
A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer (2020) (17)
Calling time on formula milk adverts (2019) (17)
Regulation of hepatic synthesis of C3 and C4 during the acute‐phase response in the rat (1989) (17)
Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization. (2016) (17)
Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer (1998) (16)
How to publish a scientific manuscript in a high‐impact journal (2014) (16)
Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer (2011) (15)
Effect of H. pylori infection on gastrin and gastric acid secretion (1994) (14)
Adaptive response of neonatal sepsis-derived Group B Streptococcus to bilirubin (2018) (14)
Gut Microbiota Signature Among Asian Post-gestational Diabetes Women Linked to Macronutrient Intakes and Metabolic Phenotypes (2021) (13)
Consensus Report infection: the Maastricht III Helicobacter pylori Current concepts in the management of (2007) (13)
The GRP test: a new clinical test of acid secretion — reproducibility data (1994) (12)
Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas (2001) (12)
Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study (2012) (12)
U.K. MRC trial of H. pylori eradication therapy for non-ulcer dyspepsia (1998) (11)
Role of endoscopic ultrasonography in predicting the response to cyclosporin A in ulcerative colitis refractory to steroids. (2009) (11)
Genetic aspects of inflammation. (2009) (10)
Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction (2022) (10)
Multi-omics analyses of airway host–microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions (2022) (10)
Polymorphisms in genes involved in Th1-type cell-mediated response and the risk of gastric cancer (2005) (10)
Loss of sensory and noradrenergic innervation in benign colorectal adenomatous polyps – a putative role of semaphorins 3F and 3A (2012) (9)
Erratum: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer (Nature (2000) 404 (398-402)) (2001) (9)
Molecular Predictors of Gastric Neoplastic Progression. (2018) (8)
Partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP 7 attenuates experimental colitis (8)
A multi-journal partnership to highlight joint first-authors of manuscripts. (2015) (8)
Not All Mice Are the Same: Standardization of Animal Research Data Presentation (2016) (7)
Transporters for Antiretroviral Drugs in Colorectal CD4+ T Cells and Circulating α4β7 Integrin CD4+ T Cells: Implications for HIV Microbicides. (2016) (7)
Colonic mucosal bacterial diversity of de novo extensive paediatric ulcerative colitis by next-generation sequencing (2011) (7)
The effects and benefits of arabinoxylans on human gut microbiota – A narrative review (2021) (7)
Urolithin A attenuates diabetes-associated cognitive impairment by ameliorating intestinal barrier dysfunction via N-glycan biosynthesis pathway. (2022) (7)
A Perspective on the Role of Microbiome for Colorectal Cancer Treatment (2021) (7)
E-cadherin germline mutations and risk of gastric cancer. (2002) (7)
Correction to Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles (2020) (7)
Dual infective burden of Helicobacter pylori and intestinal parasites: Good or bad news for the host? (2020) (7)
Not All Mice Are the Same: Standardization of Animal Research Data Presentation. (2016) (6)
MicroRNAs in gastrointestinal malignancy: a tool in cancer prevention? (2014) (6)
Application of molecular techniques in Helicobacter pylori detection: limitations and improvements (2021) (6)
The Potential Roles of Dietary Anthocyanins in Inhibiting Vascular Endothelial Cell Senescence and Preventing Cardiovascular Diseases (2022) (6)
Mechanisms involved in the development of hypochlorhydria and pangastritis in Helicobacter pylori infection (2000) (5)
Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 −/− mouse model (2021) (5)
Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases (2022) (5)
Microbiome Understanding in Maternity Study (MUMS), an Australian prospective longitudinal cohort study of maternal and infant microbiota: study protocol (2020) (5)
J-Edited DIffusional Proton Nuclear Magnetic Resonance Spectroscopic Measurement of Glycoprotein and Supramolecular Phospholipid Biomarkers of Inflammation in Human Serum. (2022) (5)
Methodological advances and challenges in probiotic bacteria production: Ongoing strategies and future perspectives (2021) (5)
Interleukin-10 promoter polymorphisms influence risk of chronic H. pylori infection (2000) (5)
How to write a Letter to the Editor (2020) (4)
A functional toll like receptor 4 polymorphism increases risk of gastric cancer (2004) (4)
The role of microaerophilic colonic mucosal bacteria in de novo paediatric inflammatory bowel disease (2011) (4)
Effect of H pylori eradication on the severity of dyspeptic symptoms in du patients - a one year follow up study (1995) (4)
Helicobacter pylori susceptibility in the GWAS era. (2013) (4)
Joint associations of adiposity and alcohol consumption with liver disease-related morbidity and mortality risk: findings from the UK Biobank (2021) (4)
Long‐Term Follow‐up after Eradication of Helicobacter pylori with Omeprazole, Clarithromycin, and Tinidazole (OCT Regimen) in a Japanese Population (2005) (4)
W1208 Variable Detection of Entero-Hepatic Helicobacter Species in Colonic Mucosal Pinch Biopsies By Different Molecular Techniques (2008) (4)
OC-074 The Role of the Fungal Microbiota in the Pathogenesis of De-Novo Paediatric Inflammatory Bowel Disease using next Generation Sequencing (2013) (3)
Bilirubin Has Anti-Bacterial Properties Against Gram-Positive Bacteria: A Potential Benefit of Physiological Jaundice? (2011) (3)
Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers 1 1 It was displayed on (1999) (3)
A multi-journal partnership to highlight joint first-authors of manuscripts (2015) (3)
What is the optimal therapy for the eradication of Helicobacter pylori? (2006) (3)
DNA typing for Helicobacter pylori isolates from eradication‐failed patients: comparison of the isolates before and after therapy (2004) (3)
Iron deficiency and Helicobacter pylori-induced gastric cancer: too little, too bad. (2013) (3)
Editorial: Genetics of Barrett's: The Bigger, the Better (2012) (3)
Genetic predisposition for Helicobacter pylori infection - the jury is still out! (2022) (3)
IL-1beta and IL-10 genotypes in a high gastric cancer risk province in China (2001) (3)
Not All Mice Are the Same: Standardization of Animal Research Data Presentation (2016) (3)
Highlights from this issue (2013) (3)
Symposium: gastroenterologyInflammatory bowel disease (2010) (3)
Bacterial extracellular vesicles and their novel therapeutic applications in health and cancer (2022) (3)
W1180 Are Non-Pylori Helicobacter Organisms Associated with Paediatric Ulcerative Colitis? Retrospective Observational Study (2009) (2)
Sa1972 Assessment of Bacterial Diversity in Colorectal Adenomatous Polyps (2013) (2)
Mo1584 Genetic Variation in C20orf54, PLCE1 and MUC1 and Risk of Upper Gastrointestinal Cancers in Caucasian Populations (2012) (2)
H. PYLORI-ASSOCIATED HYPOCHLORHYDRIA. AUTHORS' REPLY (1998) (2)
Gut goes from strength to strength (2011) (2)
Risk of malignant progression of (2)
How to be a Good Reviewer for a Scientific Journal. (2022) (2)
The P4 Study: Postpartum Maternal and Infant Faecal Microbiome 6 Months After Hypertensive Versus Normotensive Pregnancy (2022) (2)
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial. (2022) (2)
Gut Mucosal Microbiome Signatures of Colorectal Cancer Differ According to BMI Status (2022) (2)
A functional toll-like receptor 4 polymorphism increases risk of H. pylori-induced premalignant changes (2003) (2)
Gastric Tumors: an overview (2011) (2)
Fecal DNA Virome Is Associated with the Development of Colorectal Neoplasia in a Murine Model of Colorectal Cancer (2022) (2)
The clinician’s guide to acid/peptic disorders and motility disorders of the gastrointestinal tract (2007) (2)
Inflammatory bowel disease and the gut microbiota (2021) (2)
Additional file 1: of Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease (2018) (1)
Aberdeen Microarray and PET in Optimising Oesophagogastric Cancer Response-1 (AMPETOOR-1). Preliminary Results: Preliminary Results (2010) (1)
Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7 (2022) (1)
Duodenal ulcer healing drugs (1994) (1)
Interleukin-1B-enhancing genotypes are associated with increased risk of gastric cancer and its precursors (2000) (1)
H pylori infection and dyspepsia within the general population (1995) (1)
A multi-journal partnership to highlight joint first-authors of manuscripts. (2015) (1)
PTU-255 Characterisation of drug transporter gene expression in colorectal tissue and cell lines: induction with anti-retrovirals for microbicide optimisation (2015) (1)
Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing (2022) (1)
Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s Disease (2013) (1)
DOP010 Epigenome-wide analysis in childhood-onset Crohn's disease implicates MIR21 in pathogenesis and identifies multiple methylation-based diagnostic biomarkers (2014) (1)
Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study (2012) (1)
Helicobacter pylori: getting to grips with the guidance (2020) (1)
630 – Gut Microbiota Modulates the Chemopreventive Efficacy of Aspirin on Colon Cancer Through Reducing Aspirin Bioavailability (2019) (1)
Programmed Chemotherapy for Patients with Metastatic Unresectable Gastric Cancer (2012) (1)
OC-003 Genome-wide Epigenetic Analysis In Childhood-onset Crohn’s Disease Implicates Mir21 (2014) (1)
Integrating the Gut Microbiome and Stress-Diathesis to Explore Post-Trauma Recovery: An Updated Model (2022) (1)
Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination (2022) (1)
Osteopontin Exacerbates High-Fat Diet-Induced Metabolic Disorders in a Microbiome-Dependent Manner (2022) (1)
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma (2021) (1)
Disrupted establishment of anaerobe and facultative anaerobe balance in preterm infants with extrauterine growth restriction (2022) (1)
Helicobacter pylori, Peptic Ulcer Disease and Gastric Cancer (2019) (1)
IL-8-251 promoter polymorphism and risk of gastric cancer in white and Japanese populations (2005) (1)
Highlights from this issue (2012) (1)
A multi‐journal partnership to highlight joint first‐authors of manuscripts (2015) (1)
Helicobacter pylori gastritis and gastric acid secretory function — an integrated approach (1996) (1)
The role of interleukin-1 beta and other potential genetic markers as indicators of gastric cancer risk (2016) (1)
Role of Host Genetic Susceptibility in the Pathogenesis of Gastric Cancer (2009) (1)
Highlights from this issue (2012) (0)
Highlights from this issue (2011) (0)
The Polymorphism Interleukin 8-251 A/T Is Associated with Reflux Esophagitis in Heliobacter pylori-Negative Populations: 3 (2008) (0)
Highlights from this issue (2013) (0)
The ninety-fifth annual general meeting of the association of physicians of Great Britain and Ireland 2001 (2001) (0)
Highlights from this issue (2013) (0)
OC-072 The Microaerophilic Microbiota of De-Novo Paediatric Inflammatory Bowel Disease: the Biscuit Study (2013) (0)
196. The P4 study: Postpartum maternal and infant faecal microbiome 6 months after hypertensive versus normotensive pregnancy (2018) (0)
Highlights from this issue (2014) (0)
PWE-026 Elucidating the pathogenic potential of the intestinal pathogen campylobacter showae (2017) (0)
35Analysis of Single Nucleotide Polymorphisms in the Interleukin-1B Gene Using 5′ Nuclease Assays (2001) (0)
Highlights from this issue (2012) (0)
Sa1467 Development and Initial Validation of Prognostic Scoring Systems for Lower Gastrointestinal Bleeding (2013) (0)
The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses (2022) (0)
Cancer Cell Previews in survival of patients with advanced disease (2018) (0)
Could Helicobacterorganisms cause in£ammatory bowel disease? (2010) (0)
Esophageal cancers and Helicobacter pylori: do host genes matter? (2010) (0)
Digest (2010) (0)
Highlights from this issue BMI is a better predictor of response to PPIs in dyspeptics with normal endoscopy Pancolonic chromoendoscopy with indigo carmine (0)
Highlights from this issue (2011) (0)
Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice (2018) (0)
Highlights from this issue (2011) (0)
The effect of Helicobacter pylori infection on gastric acid secretion in man (1995) (0)
A Tale of Two Fibres: a Liver Twist! (2022) (0)
Digest (2010) (0)
Relationship between Diet Quality and Maternal Stool Microbiota in the MUMS Australian Pregnancy Cohort (2023) (0)
PWE-048 THE ROLE OF MICROAEROPHILIC COLONIC MUCOSAL BACTERIA IN DE NOVO PAEDIATRIC INFLAMMATORY BOWEL DISEASE (2011) (0)
Highlights from this issue (2012) (0)
Highlights from this issue (2012) (0)
Digest (2011) (0)
Report the Maastricht V / Florence Consensus − − infection Helicobacter pylori Management of (2016) (0)
Gastric secretion in H.pylori infection (1997) (0)
OC-048 Impact of the TLR4 Asp299gly polymorphism on induction of the inflammatory response following Helicobacter pylori infection (2010) (0)
Expression of cyclooxygenase-2 in human sporadic colorectal adenomas (2006) (0)
Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease (2018) (0)
The Role of the Microaerophilic Colonic Microbiota in De-Novo Paediatric Inflammatory Bowel Disease (2011) (0)
Assessment of inflammation within sporadic colorectal polyps (2006) (0)
Duodenal ulcer healing drugs. (1994) (0)
Non-invasive H. pylori testing versus endoscopy with H. pylori testing for dyspepsia (2001) (0)
7TH ANNUAL SCIENTIFIC MEETING (2014) (0)
Gut's golden anniversary and a new Editor-in-Chief (2010) (0)
Highlights from this issue (2013) (0)
W1738 Role of TLR4 in Carcinogenesis and Tumor Progression of Colorectal Cancer (2010) (0)
Highlights from this issue (2012) (0)
Helicobacter pylori Infection Precedes Gastric Hypochlorhydria in Cancer Relatives , and H . pylori Virulence Evolves inThese Families (2008) (0)
PTU-154 HMGB1 As a Prognostic Biomarker in The Progression of Barrett’s Oesophagus (2016) (0)
cance ofprogastrin-derived peptides as putative autocrine or paracrine trophic factors in this disease. (1995) (0)
OC-052 Assessment of novel genetic polymorphisms and risk of upper gastrointestinal carcinoma (2010) (0)
815 – Long-Term Changes of Gut Microbiota, Antibiotic Resistance, and Metabolic Parameters After Helicobacter Pylori Eradication with Triple, Concomitant, and Bismuth Quadruple Therapies - a Multicenter Randomized Trial (2019) (0)
Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion (2022) (0)
S1640 Can Helicobacter pylori Lipopolysaccharide Lipid a Composition Affect Its Ability to Induce an Inflammatory Response Through Toll Like Receptor 4 (2010) (0)
Adaptive response of neonatal sepsis-derived Group B Streptococcus to bilirubin (2018) (0)
Extending colonic mucosal microbiome analysis—assessment of colonic lavage as a proxy for endoscopic colonic biopsies (2016) (0)
Highlights from this issue (2012) (0)
Highlights from this issue (2014) (0)
Highlights from this issue (2012) (0)
T1807 A Single Nucleotide Polymorphism in the TLR9 Promoter (TLR9 −1237T/C) Increases the Affinity of NF-κB Protein Binding and Enhances Transcriptional Activity Upon H. pylori Infection (2008) (0)
169 Assessment of Community Structure and Predictive Functional Profiling of the Mucosa-Associated Microbiome Implicates Alterations in Benzoate Metabolism in ‘de novo’ IBD After Pouch-Surgery and in Treatment-Naïve Pediatric IBD (2015) (0)
Assessment of inflammatory cell phenotype in sporadic hyperplastic polyps (2007) (0)
PWE-075 Lack of association between the PSCA rs2294008 polymorphism, or PSCA expression, and colorectal neoplasia (2012) (0)
Highlights from this issue (2013) (0)
Helicobacter pylori infection. (2023) (0)
Characterization analysis of gut and bile microbiota for cholangiocarcinomas. (2022) (0)
Vasculitis, Gastrointestinal Manifestations of (2020) (0)
Development of a Helicobacter genus DNA probe for fluorescent in situ hybridization in gastrointestinal clinical samples (2005) (0)
Innate immune response gene polymorphisms and their role in H pylori induced precancerous changes (2006) (0)
Highlights from this issue (2014) (0)
Ferulic acid attenuates high-fat diet-induced hypercholesterolemia by activating classic bile acid synthesis pathway (2022) (0)
Highlights from this issue (2011) (0)
Highlights from this issue (2013) (0)
S1641 Impact of the TLR4 Asp299Gly Polymorphism on Induction of the Inflammatory Response Following H. pylori Infection (2010) (0)
Digest (2010) (0)
Digest (2010) (0)
The Microbiome for Gastroenterologists (2015) (0)
Gastric cancer relatives have a high prevalence of IL-18 and TGF-B1 proinflammatory genotypes (2003) (0)
Highlights from this issue (2014) (0)
Highlights from this issue (2014) (0)
OC-053 Can Helicobacter pylori lipopolysaccharide lipid a composition affect its ability to induce an inflammatory response through Toll-like receptor 4 (2010) (0)
Supplementary_Information_for_TAM – Supplemental material for A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer (2020) (0)
How accurate are fecal tests for determination of cure after Helicobacter pylori eradication therapy? (2007) (0)
Faculty Opinions recommendation of Long term follow up of patients treated for Helicobacter pylori infection. (2006) (0)
S1996 Role of Chronic Inflammation in Sporadic Colorectal Neoplasia (2008) (0)
PP-012 Cytokine gene polymorphisms, cytokine levels and risk of colorectal neoplasia in the screened population of northeast Scotland (2010) (0)
Influence of host gene polymorphisms on development of gastroduodenal diseases (2016) (0)
Gastric Cancer in the Elderly (2003) (0)
Dysbiosis in Head and Neck Cancer: Determining Optimal Sampling Site for Oral Microbiome Collection (2022) (0)
Digest (2010) (0)
Highlights from this issue (2014) (0)
Risk Factors of Helicobacter pylori Infection in the Jamaica Mother Infant Cohort Study [abstract]: (2002) (0)
Highlights from this issue (2011) (0)
Prevalence of atrophy and hypochlorhydria is high in gastric cancer relatives and related to H. pylori status (1998) (0)
IDDF2022-ABS-0052 Effect of gut influence on the immune environment in pre-clinical HCC (2022) (0)
Highlights from this issue (2011) (0)
A multi-journal partnership to highlight joint first-authors of manuscripts. (2015) (0)
Highlights from this issue (2010) (0)
GP management of dyspepsia. (2006) (0)
Update from EIC 2013 (2013) (0)
Microbial diversity and carbohydrate expression in healthy and neoplastic colonic tissue (2004) (0)
880: THE SHORT-TERM AND LONG-TERM IMPACTS OF H. PYLORI ERADICATION ON THE ANTIBIOTIC RESISTANCE AND RESISTOME OF GUT MICROBIOTA- A MULTICENTER RANDOMIZED TRIAL (2022) (0)
Risk of physical activity and hepatobiliary diseases: east meets west (2020) (0)
PTU-035 Development and Initial Validation of Prognostic Scoring Systems for lower Gastrointestinal Bleeding (2013) (0)
T2012 Cytokine Gene Polymorphisms, Cytokine Levels and Risk of Colorectal Neoplasia in the Screened Population of Northeast Scotland (2010) (0)
Predictors of failure of pneumatic dilatation in Achalasia (0)
Helicobacter pylori and Gastric Acid Hypersecretion in Duodenal Ulcer Patients (2007) (0)
COX-2 gene polymorphisms and association with premalignant changes in the stomach (2005) (0)
Differential response to adjuvant chemotherapy based on Lauren subtype affects clinical outcome of gastric cancer: A cohort study and meta-analysis. (2018) (0)
Not all mice are the same: Standardization of animal research data presentation. (2016) (0)
Therapeutic Strategies in Diseases of the Digestive Tract - 2015 and Beyond: Falk Symposium 200, Freiburg, October 2015: Official Congress Report (2016) (0)
Epithelial Barrier Function (2020) (0)
Highlights from this issue (2012) (0)
PWE-012 Assessment of Bacterial Diversity in Colorectal Adenomatous Polyps (2013) (0)
Digest (2010) (0)
Anticancer effects of bioactive berry compounds (2013) (0)
Highlights from this issue (2011) (0)
Table of contents (2016) (0)
Detection of Helicobacter species in archival human UC colorectal tissue by fluorescent in situ hybridization (FISH) (2005) (0)
Digest (2010) (0)
Tumors of the stomach (2022) (0)
Highlights from this issue (2013) (0)
Digest (2010) (0)
Highlights from this issue (2013) (0)
Bacterial Diversity of the Colonic Microbiota in De-Novo Extensive Paediatric Ulcerative Colitis by Next-Generation Sequencing (2011) (0)
The Effect of Lactulose on the Faecal Microbiota of Patients with Minimal Hepatic Encephalopathy (2017) (0)
Ablation of fucosyl transferase homologs has varying effects on H. Pylori lewis antigen expression (1998) (0)
Highlights from this issue (2011) (0)
Digest (2010) (0)
PWE-013 Evaluation of Faecal Aspirate as a Proxy for Colonoscopy Biopsy Sampling to Assess Microbial Diversity (2013) (0)
IDDF2019-ABS-0188 Gut microbiota modulates the chemopreventive efficacy of aspirin on colorectal cancer through impact on aspirin bioavailability (2019) (0)
946 Genome-Wide Analysis of DNA Methylation in Low-Grade Colorectal Adenomas and Normal Colonic Mucosa (2014) (0)
Highlights from this issue (2012) (0)
Assessment of macrophage function within the stroma of sporadic colorectal polyps (2007) (0)
hepatic cytokine and chemokine (0)
Connective Tissue Disorders, Gastrointestinal Tract Manifestations of (2020) (0)
SERUM GASTRIN LEVELS AND COLORECTAL NEOPLASIA. AUTHORS' REPLY (1995) (0)
HELICOBACTER PYLORI ERADICATION, DUODENAL ULCER HEALING, AND GASTRIC SECRETORY STATE. AUTHORS' REPLY (1994) (0)
Reply (1994) (0)
Tu1729 Evaluation of Fecal Aspirate As a Proxy for Colonoscopy Biopsy Sampling to Assess Microbial Diversity (2013) (0)
Hightlights from this issue (2013) (0)
Highlights from this issue (2011) (0)
Digest (2010) (0)
Tu1704 The Role of the Fungal Microbiota in the Pathogenesis of De-Novo Pediatric Inflammatory Bowel Disease Using Next Generation Sequencing (2013) (0)
Detection of campylobacter concisus in colonic biopsies from adult patients with ulcerative colitis (2011) (0)
IDDF2019-ABS-0213 Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after helicobacter pylori eradication- a multicentre randomised trial (2019) (0)
Corrigendum: The P4 Study: Postpartum Maternal and Infant Faecal Microbiome 6 Months After Hypertensive Versus Normotensive Pregnancy (2022) (0)
Highlights from this issue (2004) (0)
Digest (2011) (0)
Highlights from this issue (2011) (0)
Critical Assessment of Whole Genome and Viral Enrichment Shotgun Metagenome on the Characterization of Stool Total Virome in Hepatocellular Carcinoma Patients (2022) (0)
Hepatology Basic Science (2022) (0)
Highlights from this issue (2013) (0)
PWE-109 Cytoplasmic Expression of HMGB1 is Associated with Early Colorectal Carcinogenesis (2016) (0)
Ten reasons gastroenterologists and hepatologists should be treating obesity (2023) (0)
Digest (2010) (0)
Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 −/− mouse model (2021) (0)
Faculty Opinions recommendation of Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo. (2007) (0)
Su1957 - Fecal Microbiota Transplantation Confers Beneficial Metabolic Effects of Diet and Exercise on Diet-Induced Obese Mice (2018) (0)
T2009 Assessment of Novel Genetic Polymorphisms and Risk of Upper Gastrointestinal Carcinoma (2010) (0)

This paper list is powered by the following services:

Other Resources About Emad El-Omar

What Schools Are Affiliated With Emad El-Omar?

Emad El-Omar is affiliated with the following schools:

Emad El-Omar's Academic­Influence.com Rankings